Why This Matters: As countries compete to attract research investment and secure early access to innovative medicines, understanding global pricing dynamics is critical to protecting Canada’s health future.
This article from the Pharmacy Times explains why Americans have been paying far more for prescription drugs than people in other wealthy nations, and how international reference pricing models influence where pharmaceutical companies launch new medicines and invest in research.